Drugs for benign prostatic hypertrophy

被引：14

作者：

Jiwrajka, Manasi ^{[1
]}

Yaxley, William ^{[1
]}

Ranasinghe, Sachinka ^{[1
]}

Perera, Marlon ^{[1
,2
,3
]}

Roberts, Matthew J. ^{[1
,2
]}

Yaxley, John ^{[1
,2
]}

机构：

[1] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia

[2] Univ Queensland, Fac Med, Brisbane, Qld, Australia

[3] Univ Melbourne, Austin Hlth, Dept Surg, Melbourne, Vic, Australia

来源：

AUSTRALIAN PRESCRIBER | 2018年 / 41卷 / 05期

关键词：

alpha blockers; 5-alpha-reductase inhibitors; benign prostatic hyperplasia;

D O I：

10.18773/austprescr.2018.045

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Benign prostatic hyperplasia is a common condition. It can cause problems with urine storage and voiding, and the severity of symptoms may be unrelated to the size of the prostate. When drug treatment is required, benign prostatic hyperplasia can be managed with monotherapy or combination therapy. Most patients are managed with selective alpha blockers. Patients with larger prostate volumes may benefit from a 5-alpha-reductase inhibitor, usually in combination with an alpha blocker.

引用

页码：150 / 153

页数：4

共 30 条

[1] American Urological Association, 2010, AM UROLOGICAL ASS GU
[2] Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: Results of a randomized, double-blind, placebo-controlled clinical trial
Andriole, GL
Guess, HA
Epstein, JI
Wise, H
Kadmon, D
Crawford, ED
Hudson, P
Jackson, CL
Romas, NA
Patterson, L
Cook, TJ
Waldstreicher, J
[J]. UROLOGY, 1998, 52 (02) : 195 - 201
[3] Aumuller G, 1996, ACTA ANAT, V156, P241
[4] Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials
Boyle, P
Gould, AL
Roehrborn, CG
[J]. UROLOGY, 1996, 48 (03) : 398 - 405
[5] Bruskewitz Reginald C, 2003, Rev Urol, V5, P72
[6] Charles J, 2011, AUST FAM PHYSICIAN, V40, P757
[7] Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis
Dahma, Philipp
Brasure, Michelle
MacDonald, Roderick
Olson, Carin M.
Nelson, Victoria A.
Fink, Howard A.
Rwabasonga, Bruce
Risk, Michael C.
Wilt, Timothy J.
[J]. EUROPEAN UROLOGY, 2017, 71 (04) : 570 - 581
[8] European Association of Urology Guidelines, 2018, TREATM NONN MAL LUTS
[9] 5 Alpha-reductase inhibitors: what's new?
Foley, CL
Kirby, RS
[J]. CURRENT OPINION IN UROLOGY, 2003, 13 (01) : 31 - 37
[10] 5-Alpha-Reductase Inhibitors and Combination Therapy
Fuellhase, Claudius
Schneider, Marc P.
[J]. UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (03) : 325 - +

← 1 2 3 →